Zyprexa News

Zyprexa is frequently in the headlines of many media organizations, but it is doubtful Eli Lilly & Co desires the types of publicity their product receives. Numerous individual and class action lawsuits in recent months have cast new light on the dangers Zyprexa poses to uninformed patients. As media outlets focus more and more on the cases of diabetes, stroke, and obesity caused by Zyprexa, those who prescribe and take the drug have a greater knowledge of the risks it poses which could possibly save lives. In addition to being lambasted in print and on the internet, Zyprexa has been the news topic of numerous radio and television talk shows, and continues to fuel nationwide debate on the role negligence and responsibility of pharmaceutical companies worldwide.

Click on the links below to read recent news articles about Zyprexa:

06/09/05
Lilly and Plaintiffs' Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa(R) Product Liability Litigation

03/08/05
Lawsuit Launched Over Antipsychotic Drug

02/08/05
FDA Warns Of Antipsychotic, Antihistamine Drug Mixup

01/27/04
Antipsychotic Drugs Raise Diabetes Risk

01/27/04
Caution Urged on Anti-Psychotic Drugs

02/21/04
Lilly Warns of Zyprexa Risk for Elderly

12/07/04
Discovery Limited In Zyprexa Case

9/2/2003
Zyprexa, Risperdal and Clozaril May Increase Risk of Pancreatitis

First Name
Last Name
Phone - -
Email
Address
Zip
Comments
By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.

By leaving this box checked, I agree to receive future advertisements and announcements from our firm, its affiliates and partners.
I agree that submitting this form and the information contained within does not establish an attorney client relationship.
I agree that my information will be reviewed by more than one attorney and/or law firm.
I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question and I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Since this matter may require advice regarding my home state, I agree that local counsel may be contacted for referral of this matter.
By clicking the Submit button, I agree to wiselawgroup’s Privacy Policy and Terms and Conditions and I am also providing my express consent to receive pre-recorded marketing messages from wiselawgroup, it’s affiliates and partners as set forth here.

Zyprexa News

Zyprexa News

Topics